Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
P.J. Jost
Observed name:
P. J. Jost
Institutions:
Medical University of Graz,
BioTechMed-Graz
Observed institutions:
Medical University of Graz,
BioTechMed-Graz
ORCID:
0000-0003-2454-0362
Observed ORCID:
0000-0003-2454-0362
OpenAlex ID:
A5076946477
Integrating baseline ctDNA-derived tumor metrics enhances risk stratification in HR-positive/HER2-negative advanced breast cancer: a real-world multicenter cohort study from Austria
2026
·
N. Dobrić
, S.O. Hasenleithner
, et al.
·
ESMO Open
·
3
Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study
2026
·
F. Moik
, F. Huemer
, et al.
·
ESMO Open
·
2
Abstract PS1-12-20: Circulating tumor DNA profiling of patients with early-line advanced luminal breast cancer
2026
·
N. Dobrić
, S. O. Hasenleithner
, et al.
·
Clinical Cancer Research
315P Molecular testing in lung squamous cell carcinoma using DNA- and RNA-based next-generation sequencing: A single-center experience
2022
·
L. Brcic
, M. Zacharias
, et al.
·
Annals of Oncology
EP02.01-008 Clinicopathological Features of Rare but Targetable Mutations in Surgically Resected Lung Carcinomas
2022
·
M. Zacharias
, S. Konjic
, et al.
·
Journal of Thoracic Oncology
PDF
Show more works
View as search
Works count:
5
Citation count:
5
H-index:
2
I10-index:
Year
Topic
Type